Tracking The Risk Factors Associated With High-Risk Cscc: A 10-Year, Two-Institution, Greek Study

Emmanouil Dimonitsas, Gregory Champsas,Despoina Kakagia, Spiros D Stavrianos,Sotirios Roussos, Ortansia Doryforou, Foteini Neamonitou,Efthymia Soura,Epameinondas Kostopoulos,Errieta Christofidou, Othon Papadopoulos, Irene Thymara, Nikolaos A Papadopoulos, Alexandros Stratigos,Penelope Korkolopoulou

JOURNAL OF BUON(2021)

引用 0|浏览3
暂无评分
摘要
Purpose: We sought to identify independent risk factors for positive sentinel lymph node biopsy (SLNB), local recurrence (LR), metastasis (M) and death caused by cutaneous squamous cell carcinoma (cSCC) (DCS) in high-risk cSCC patients. Moreover, we compared the Brigham and Women's Hospital (BWH) system with the previous used in Greece (based on tumor size) and proposed a new classification system.Methods: 1,524 cSCC patients were enrolled between January 2004 and December 2014, from two medical institutions. Potential risk factors for SLNB (local recurrence/LR, metastasis/M, death caused by SCC/DCS) were analyzed by univariate and multivariate Cox logistic regression models.Results: Of the included patients with a median follow-up of 60 months 107 developed local recurrence (7%) while 84 developed metastases (5.5%). Among 36 patients undergoing sentinel lymph node biopsy (SLNB), 25% showed a positive SLNB with a false-negative result (11%). On multivariate analysis, key prognostic factors for LR were tumor diameter >2 cm, poor differentiation, incomplete excision and perineural invasion and for M were high-risk tumor site, tumor diameter >2 cm, poor differentiation, invasion beyond subcutaneous tis- sue, incomplete excision, perineural invasion and recurrence. DCS seems to be affected by tumor diameter > 2 cm, poor differentiation, invasion beyond subcutaneous tissue, incomplete excision, perineural invasion and recurrence independently.Conclusions: These suggest the determined role of tumor diameter of cSCCs. Harnessing knowledge and collecting the up-to-date data along the clinical journey of high-risk cSCC, the future looks bright (development of new clinical trials, adjuvant therapies and tumor staging with SLNB).
更多
查看译文
关键词
cutaneous squamous cell carcinoma, cSCC, high-risk cSCC, prognosis, sentinel lymph node biopsy, staging criteria
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要